149 related articles for article (PubMed ID: 12591732)
1. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
2. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
3. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.
Goebel SU; Iwamoto M; Raffeld M; Gibril F; Hou W; Serrano J; Jensen RT
Cancer Res; 2002 Jul; 62(13):3702-10. PubMed ID: 12097278
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J
Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598
[TBL] [Abstract][Full Text] [Related]
5. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
[TBL] [Abstract][Full Text] [Related]
7. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
[TBL] [Abstract][Full Text] [Related]
8. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance of chromosome 1q in esophageal squamous cell carcinomas from China: a novel region of allelic loss and significant association with differentiation.
Li J; Liu Z; Wang Y; Yu Z; Wang M; Zhan Q; Liu Z
Cancer Lett; 2005 Apr; 220(2):221-30. PubMed ID: 15766597
[TBL] [Abstract][Full Text] [Related]
10. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
Maru DM; Luthra R; Correa AM; White-Cross J; Anandasabapathy S; Krishnan S; Guha S; Komaki R; Swisher SG; Ajani JA; Hofstetter WL; Rashid A
Cancer; 2009 Apr; 115(7):1576-85. PubMed ID: 19156915
[TBL] [Abstract][Full Text] [Related]
12. [Refined mapping of the loss of heterozygosity on chromosome 1q21 in gastric carcinoma].
Liu TF; Yin ZH; Gan RL; Zhao Q; Dong L; Zhou JG; Dong BH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1229-32. PubMed ID: 18676271
[TBL] [Abstract][Full Text] [Related]
13. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
[TBL] [Abstract][Full Text] [Related]
14. Survey of genetic alterations in gastrinomas.
Yu F; Jensen RT; Lubensky IA; Mahlamaki EH; Zheng YL; Herr AM; Ferrin LJ
Cancer Res; 2000 Oct; 60(19):5536-42. PubMed ID: 11034099
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
16. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT
Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors.
O'Leary T; Ernst S; Przygodzki R; Emory T; Sobin L
Lab Invest; 1999 Dec; 79(12):1461-7. PubMed ID: 10616197
[TBL] [Abstract][Full Text] [Related]
19. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]